DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAGP

ABCDE and ugly-duckling assessment of pigmented lesions

Essential points for quick revision.

Synopsis

Assess a pigmented lesion systematically, compare it with the patient’s mole pattern, use the weighted seven-point checklist correctly, and arrange urgent specialist assessment without unsafe destructive sampling.

  • ABCDE prompts asymmetry, border irregularity, colour variation, diameter and evolution; evolution is often the most useful single feature.
  • The ugly-duckling sign identifies a lesion that differs from the person’s background naevus pattern, even if it does not satisfy every ABCDE letter.
  • Nodular melanoma may be symmetrical, uniformly coloured and initially small; use elevated, firm and growing over weeks to months as an additional warning pattern.

Key red flags

Evolution, an ugly-duckling lesion, nodular growth, bleeding, ulceration, irregular colour or shape, nail-unit pigment extending onto skin, or a weighted seven-point score of 3 or more requires urgent suspected-cancer referral.

Nodular growth

A new elevated, firm and continuously growing papule or nodule over weeks to months can be melanoma without classic ABCD asymmetry.

Investigation priorities

01
Weighted seven-point checklistFirst step

Standardise urgent-referral assessment of a suspicious pigmented lesion.

Management branches

Suspicious pigmented lesionRefer on pattern and evolution

The weighted checklist scores 3 or more, dermoscopy suggests melanoma, or an ugly-duckling, nodular, acral or nail warning exists.

  1. Document history, measurements, morphology, patient’s comparison pattern and relevant risk factors without attempting destructive treatment.
  2. Make an urgent suspected-cancer referral using the local pathway and attach consented images only when secure systems and policy allow.
Open full textbook Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom